ID   CLK4_HUMAN              Reviewed;         481 AA.
AC   Q9HAZ1;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 137.
DE   RecName: Full=Dual specificity protein kinase CLK4;
DE            EC=2.7.12.1;
DE   AltName: Full=CDC-like kinase 4;
GN   Name=CLK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY,
RP   AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LYS-189.
RC   TISSUE=Kidney;
RX   PubMed=11170754; DOI=10.1006/geno.2000.6447;
RA   Schultz J., Jones T., Bork P., Sheer D., Blencke S., Steyrer S.,
RA   Wellbrock U., Bevec D., Ullrich A., Wallasch C.;
RT   "Molecular characterization of a cDNA encoding functional human CLK4
RT   kinase and localization to chromosome 5q35.";
RL   Genomics 71:368-370(2001).
RN   [2]
RP   ERRATUM.
RA   Schultz J., Jones T., Bork P., Sheer D., Blencke S., Steyrer S.,
RA   Wellbrock U., Bevec D., Ullrich A., Wallasch C.;
RL   Genomics 74:251-251(2001).
RN   [3]
RP   INTERACTION WITH UBL5.
RX   PubMed=12824502; DOI=10.1110/ps.0382803;
RA   McNally T., Huang Q., Janis R.S., Liu Z., Olejniczak E.T.,
RA   Reilly R.M.;
RT   "Structural analysis of UBL5, a novel ubiquitin-like modifier.";
RL   Protein Sci. 12:1562-1566(2003).
RN   [4]
RP   INTERACTION WITH UBL5.
RX   PubMed=12705895; DOI=10.1016/S0006-291X(03)00549-7;
RA   Kantham L., Kerr-Bayles L., Godde N., Quick M., Webb R.,
RA   Sunderland T., Bond J., Walder K., Augert G., Collier G.;
RT   "Beacon interacts with cdc2/cdc28-like kinases.";
RL   Biochem. Biophys. Res. Commun. 304:125-129(2003).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136 AND SER-138, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   FUNCTION, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=19168442; DOI=10.1161/CIRCRESAHA.108.183905;
RA   Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S.,
RA   Poller W., Schultheiss H.P., Rauch U.;
RT   "Cdc2-like kinases and DNA topoisomerase I regulate alternative
RT   splicing of tissue factor in human endothelial cells.";
RL   Circ. Res. 104:589-599(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-352 AND VAL-363.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual specificity kinase acting on both serine/threonine
CC       and tyrosine-containing substrates. Phosphorylates serine- and
CC       arginine-rich (SR) proteins of the spliceosomal complex and may be
CC       a constituent of a network of regulatory mechanisms that enable SR
CC       proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3.
CC       Required for the regulation of alternative splicing of MAPT/TAU.
CC       Regulates the alternative splicing of tissue factor (F3) pre-mRNA
CC       in endothelial cells. {ECO:0000269|PubMed:11170754,
CC       ECO:0000269|PubMed:19168442}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: TG003 inhibits its kinase activity and affects
CC       the regulation of alternative splicing mediated by phosphorylation
CC       of SR proteins. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with UBL5. {ECO:0000269|PubMed:12705895,
CC       ECO:0000269|PubMed:12824502}.
CC   -!- INTERACTION:
CC       P52294:KPNA1; NbExp=3; IntAct=EBI-633400, EBI-358383;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-633400, EBI-10172290;
CC       P60410:KRTAP10-8; NbExp=3; IntAct=EBI-633400, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-633400, EBI-10172052;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in liver, kidney, heart, muscle,
CC       brain and endothelial cells. {ECO:0000269|PubMed:11170754,
CC       ECO:0000269|PubMed:19168442}.
CC   -!- PTM: Autophosphorylates on all three types of residues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. Lammer subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF294429; AAG10074.1; -; mRNA.
DR   CCDS; CCDS4437.1; -.
DR   RefSeq; NP_065717.1; NM_020666.2.
DR   UniGene; Hs.406557; -.
DR   ProteinModelPortal; Q9HAZ1; -.
DR   SMR; Q9HAZ1; -.
DR   BioGrid; 121501; 18.
DR   IntAct; Q9HAZ1; 13.
DR   STRING; 9606.ENSP00000316948; -.
DR   BindingDB; Q9HAZ1; -.
DR   ChEMBL; CHEMBL4203; -.
DR   GuidetoPHARMACOLOGY; 1993; -.
DR   iPTMnet; Q9HAZ1; -.
DR   PhosphoSitePlus; Q9HAZ1; -.
DR   BioMuta; CLK4; -.
DR   DMDM; 34922132; -.
DR   EPD; Q9HAZ1; -.
DR   MaxQB; Q9HAZ1; -.
DR   PaxDb; Q9HAZ1; -.
DR   PeptideAtlas; Q9HAZ1; -.
DR   PRIDE; Q9HAZ1; -.
DR   Ensembl; ENST00000316308; ENSP00000316948; ENSG00000113240.
DR   GeneID; 57396; -.
DR   KEGG; hsa:57396; -.
DR   UCSC; uc003mjf.2; human.
DR   CTD; 57396; -.
DR   GeneCards; CLK4; -.
DR   HGNC; HGNC:13659; CLK4.
DR   HPA; HPA043746; -.
DR   MIM; 607969; gene.
DR   neXtProt; NX_Q9HAZ1; -.
DR   OpenTargets; ENSG00000113240; -.
DR   PharmGKB; PA26598; -.
DR   eggNOG; KOG0671; Eukaryota.
DR   eggNOG; ENOG410XQF2; LUCA.
DR   GeneTree; ENSGT00580000081366; -.
DR   HOGENOM; HOG000203417; -.
DR   HOVERGEN; HBG107720; -.
DR   InParanoid; Q9HAZ1; -.
DR   KO; K08823; -.
DR   OMA; CERYVPR; -.
DR   OrthoDB; EOG091G033A; -.
DR   PhylomeDB; Q9HAZ1; -.
DR   TreeFam; TF101041; -.
DR   SignaLink; Q9HAZ1; -.
DR   SIGNOR; Q9HAZ1; -.
DR   ChiTaRS; CLK4; human.
DR   GenomeRNAi; 57396; -.
DR   PRO; PR:Q9HAZ1; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113240; -.
DR   CleanEx; HS_CLK4; -.
DR   ExpressionAtlas; Q9HAZ1; baseline and differential.
DR   Genevisible; Q9HAZ1; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0043484; P:regulation of RNA splicing; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    481       Dual specificity protein kinase CLK4.
FT                                /FTId=PRO_0000085873.
FT   DOMAIN      159    475       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     165    173       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    286    286       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     189    189       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     136    136       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     138    138       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT     352    352       L -> F (in dbSNP:rs35272416).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040414.
FT   VARIANT     363    363       I -> V (in dbSNP:rs55746655).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040415.
FT   MUTAGEN     189    189       K->R: Loss of function.
FT                                {ECO:0000269|PubMed:11170754}.
SQ   SEQUENCE   481 AA;  57492 MW;  F402C36835CDA306 CRC64;
     MRHSKRTHCP DWDSRESWGH ESYRGSHKRK RRSHSSTQEN RHCKPHHQFK ESDCHYLEAR
     SLNERDYRDR RYVDEYRNDY CEGYVPRHYH RDIESGYRIH CSKSSVRSRR SSPKRKRNRH
     CSSHQSRSKS HRRKRSRSIE DDEEGHLICQ SGDVLRARYE IVDTLGEGAF GKVVECIDHG
     MDGMHVAVKI VKNVGRYREA ARSEIQVLEH LNSTDPNSVF RCVQMLEWFD HHGHVCIVFE
     LLGLSTYDFI KENSFLPFQI DHIRQMAYQI CQSINFLHHN KLTHTDLKPE NILFVKSDYV
     VKYNSKMKRD ERTLKNTDIK VVDFGSATYD DEHHSTLVST RHYRAPEVIL ALGWSQPCDV
     WSIGCILIEY YLGFTVFQTH DSKEHLAMME RILGPIPQHM IQKTRKRKYF HHNQLDWDEH
     SSAGRYVRRR CKPLKEFMLC HDEEHEKLFD LVRRMLEYDP TQRITLDEAL QHPFFDLLKK
     K
//
